Patent details

Basic Information

Publication number:

EP2727605

PCT Application Number:

KR2012005137

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP128046836

PCT Publication Number:

WO2013002580

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

EXENDIN-4 ANALOGUE PEGYLATED WITH POLYETHYLENE GLYCOL OR DERIVATIVE THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES, CONTAINING SAME AS ACTIVE INGREDIENT

French Title of Invention:

ANALOGUE D'EXENDINE-4 PÉGYLÉ PAR DU POLYÉTHYLÈNE GLYCOL OU UN DÉRIVÉ DE CELUI-CI, SON PROCÉDÉ DE PRÉPARATION ET COMPOSITION PHARMACEUTIQUE POUR PRÉVENIR OU TRAITER LE DIABÈTE, LE CONTENANT EN TANT QUE PRINCIPE ACTIF

German Title of Invention:

MIT POLYETHYLENGLYCOL ODER EINEM DERIVAT DAVON PEGYLIERTES EXENDIN-4-ANALOGON, HERSTELLUNGSVERFAHREN DAFÜR UND PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR VORBEUGUNG ODER BEHANDLUNG VON DIABETES DAMIT ALS WIRKSTOFF

SPC Number:

Dates

Filing date:

28/06/2012

Grant date:

04/04/2018

EP Publication Date:

07/05/2014

PCT Publication Date:

03/01/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/04/2018

EP B1 Publication Date:

04/04/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/06/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/10/2018

 

 

Name:

D&D Pharmatech Inc.

Address:

2nd Floor 225-18, Pangyoyeok-ro, Bundang-gu, Seongnam-si, 13493, Gyeonggi-do, Korea (Republic) (KR)

History of Owners

From:

10/10/2018

To:

10/10/2018

Name:

THERALY PHARMACEUTICALS INC.

Address:

1812 Ashland Avenue, 1st Floor, Room 100, 21205, Baltimore, Maryland, United States (US)

From:

28/03/2018

To:

10/10/2018

Name:

Theraly Pharmaceuticals Inc.

Address:

7751 Coriander Place, Elkridge, Maryland 21075, United States (US)

Agent

Name:

Office FREYLINGER S.A.

From:

13/06/2018

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

KIM, Tae Hyung

Address:

Korea (Republic) (KR)

2

Name:

KIM, Won Bae

Address:

Korea (Republic) (KR)

3

Name:

LEE, Sung Kwon

Address:

Korea (Republic) (KR)

4

Name:

LEE, Seulki

Address:

Korea (Republic) (KR)

Priority

Priority Number:

20110062858

Priority Date:

28/06/2011

Priority Country:

Korea (Republic) (KR)

Classification

IPC classification:

A61K 9/00; A61K 9/20; A61K 9/48; A61K 38/22; A61K 47/02; A61K 47/26; A61K 47/30; A61P 3/10; C07K 14/575; A61K 47/60;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2018/12

Publication date:

15/11/2018

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2018/12

Publication date:

15/11/2018

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:

201814

Publication date:

04/04/2018

Description:

Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20180000335A

Date Registered:

10/10/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Changement d'adresse

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

THERALY PHARMACEUTICALS INC.

Address:

1812 Ashland Avenue, 1st Floor, Room 100, 21205, Baltimore, United States (US)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20180000336A

Date Registered:

10/10/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

D&D Pharmatech Inc.

Address:

2nd Floor 225-18, Pangyoyeok-ro, Bundang-gu, Seongnam-si, 13493, Gyeonggi-do, Korea (Republic) (KR)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/06/2025

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

26/06/2024

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
13/06/2018	Power Of Attorney	1
25/06/2018	Outgoing Correspondence	1
10/10/2018	Request For Change	7
10/10/2018	Request For Change	1
11/10/2018	Outgoing Correspondence	1